Oncology Practice Adaptation During COVID-19 Era
Sort by:
Penn Medicine Abramson Cancer Center
Penn Medicine Melanoma Management During COVID-19: Should We Start With Neoadjuvant Treatment and Delay Surgery in Bulky Stage III Disease? Will Pts Receiving IO Have More Adverse Events? Should Pts Undergoing Treatment Get Tested?
FEATURING
Lynn Schuchter,
Christopher J. Miller
- 25 views
- November 16, 2020
Moffitt Cancer Center
Melanoma Drug Therapy During COVID-19: When to Wait or Go Forward With the Adjuvant Treatment? Does IO Help Fight Coronavirus? Are Pts on Steroids at Higher Risk for the Virus? How Long After a Treatment a Patient Should Be Monitored?
FEATURING
Zeynep Eroglu,
Vernon Sondak
- 374 views
- November 16, 2020
- 1
Total Health
Will COVID-19 Leave Its Mark on Cancer Care?
FEATURING
Gilberto Lopes
- 1,815 views
- November 6, 2020
- 6
AstraZeneca Oncology
Continuing Lung Cancer Diagnosis, Workup, & Care Across the Spectrum of the COVID-19 Pandemic
- 1,683 views
- September 25, 2020
- 4
Samuel M. Silver
COVID-19 & Oncology: How to Prepare Your Oncology Clinic for COVID-19 Infections?
FEATURING
Debra Patt
- 3 views
- September 14, 2020
Penn Medicine 2020 Updates in Oncology
COVID-19 Database Learnings and National Organization Responses: What Are the Current Clinical Guidelines for Cancer Patients? How Has Information Been Disseminated and Will We Be Able to Define Optimal Care in the Future?
FEATURING
Lawrence Shulman
- 33 views
- August 26, 2020
Penn Medicine 2020 Updates in Oncology
2020 ASCO Penn Medicine Breaking News: Anticoagulation Regimens During COVID-19, HER2 Directed Therapies & Tolerability of BRAF Therapy in CRC
FEATURING
Joshua Bauml,
Pallavi Kumar,
Lynn Schuchter,
Jennifer Eads,
David Mintzer,
James Gerson,
Allyson Pishko
- 12 views
- July 16, 2020